Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.04 -0.28 (2.71%)
Previous Close $10.32    52 Week High $9.23 
Open $10.42    52 Week Low $1.16 
Day High $10.48    P/E N/A 
Day Low $10.02    EPS $-0.30 
Volume 696,910       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.04 -0.28 (2.71%)
Previous Close $10.32    52 Week High $9.23 
Open $10.42    52 Week Low $1.16 
Day High $10.48    P/E N/A 
Day Low $10.02    EPS $-0.30 
Volume 696,910